Arioglu-Inan Ebru, Ozakca Isil, Kayki-Mutlu Gizem, Sepici-Dincel Aylin, Altan Vecdi Melih
Ankara University, Faculty of Pharmacy, Department of Pharmacology, 06100 Tandogan, Ankara, Turkey.
Eur J Pharmacol. 2013 Oct 15;718(1-3):533-43. doi: 10.1016/j.ejphar.2013.06.021. Epub 2013 Jun 27.
β-adrenoceptor-mediated responses are known to be attenuated in diabetic rat hearts, related to decreased receptor sensitivity and density. These impaired responses were improved with insulin in diabetic rats, but not in thyroidectomized diabetic rats. We aimed to investigate the possible interaction between insulin and thyroid hormones to restore diabetes-induced alterations on β-adrenoceptor-mediated responses. Male Sprague-Dawley rats were divided into seven groups: control (C), diabetic (D), insulin-treated diabetic (DI), thyroidectomized diabetic (TxD), insulin-treated thyroidectomized diabetic (TxDI), insulin+low dose 3,3',5-triiodo-L-thyronine (T3) treated (TxDIT2.5) or insulin+high dose T3 (TxDIT5) treated thyroidectomized diabetic rats. Diabetes was induced with 38 mg/kg streptozotocin. Cardiac function was assessed through pressure-volume analysis and papillary muscle experiments. QPCR and western blot experiments were performed to evaluate cardiac gene expressions. Hemodynamic parameters were impaired in diabetes, and were mostly corrected in DI and TxDIT5 groups. Isoprenaline- and BRL37344-induced contractile responses were also decreased in diabetes. Isoprenaline responses were improved significantly in DI and TxDIT5 groups, whereas BRL 37344-mediated responses were increased slightly. Reduced β1-adrenoceptor and SERCA 2A mRNA levels in diabetes were corrected in DI and TxDIT5 groups. Decreased SERCA 2A and increased β3-adrenoceptor protein levels in diabetes were improved in DI and TxDIT5 groups. No significant changes were found in phospholamban or endothelial nitricoxide synthase protein levels. These results show that the beneficial effects of insulin on β-adrenoceptor-mediated responses in diabetic rats are dependent upon adequate concentrations of thyroid hormones.
已知β-肾上腺素能受体介导的反应在糖尿病大鼠心脏中会减弱,这与受体敏感性和密度降低有关。这些受损反应在糖尿病大鼠中可通过胰岛素得到改善,但在甲状腺切除的糖尿病大鼠中则不然。我们旨在研究胰岛素与甲状腺激素之间可能的相互作用,以恢复糖尿病引起的β-肾上腺素能受体介导反应的改变。雄性Sprague-Dawley大鼠分为七组:对照组(C)、糖尿病组(D)、胰岛素治疗糖尿病组(DI)、甲状腺切除糖尿病组(TxD)、胰岛素治疗甲状腺切除糖尿病组(TxDI)、胰岛素+低剂量3,3',5-三碘-L-甲状腺原氨酸(T3)治疗组(TxDIT2.5)或胰岛素+高剂量T3(TxDIT5)治疗的甲状腺切除糖尿病大鼠。用38mg/kg链脲佐菌素诱导糖尿病。通过压力-容积分析和乳头肌实验评估心脏功能。进行QPCR和蛋白质印迹实验以评估心脏基因表达。糖尿病时血流动力学参数受损,在DI组和TxDIT5组中大多得到纠正。糖尿病时异丙肾上腺素和BRL37344诱导的收缩反应也降低。DI组和TxDIT5组中异丙肾上腺素反应显著改善,而BRL 37344介导的反应略有增加。糖尿病时降低的β1-肾上腺素能受体和肌浆网Ca2+-ATP酶2A(SERCA 2A)mRNA水平在DI组和TxDIT5组中得到纠正。糖尿病时降低的SERCA 2A和升高的β3-肾上腺素能受体蛋白水平在DI组和TxDIT5组中得到改善。受磷蛋白或内皮型一氧化氮合酶蛋白水平未发现显著变化。这些结果表明,胰岛素对糖尿病大鼠β-肾上腺素能受体介导反应的有益作用取决于甲状腺激素的适当浓度。